section name header

Information

These organisms generally cause a spectrum of disease similar to that caused by other GNB, including pneumonia (particularly ventilator-associated), UTI (especially catheter-related), intravascular device-related infection, surgical-site infection, and abdominal infections.

Treatment: Infections Caused by Other Gram-Negative Enteric Pathogens

  • Significant antibiotic resistance among these organisms makes therapy challenging.
    • - Many of these organisms (e.g., Serratia, Providencia, Acinetobacter, Citrobacter, Enterobacter, Morganella) have a derepressible AmpC β-lactamase that results in resistance to third-generation cephalosporins, monobactams, and—in many cases—β-lactam/β-lactamase inhibitor combinations.
    • - Morganella and Providencia are inherently resistant to the polymyxins and tigecycline.
  • Carbapenems and amikacin are most reliably active, and fourth-generation cephalosporins are active provided the organism does not express an ESBL. Susceptibility testing is essential. Some isolates may retain susceptibility only to colistin and polymyxin B.

Outline

Section 7. Infectious Diseases